Olanzapine versus Risperidone: A Prospective Comparison of Clinical and Economic Outcomes in Schizophrenia

By Edgell E.T.  

PharmacoEconomics, Vol. 18, Iss. 6, 2000-12 ,pp. : 567-579

Adis International

Access to resources Recommend Favorite

Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial

By Beasley C.M.   Hamilton S.H.   Crawford A.M.   Dellva M.A.   Tollefson G.D.   Tran P.V.   Blin O.   Beuzen J.-N.  

European Neuropsychopharmacology, Vol. 7, Iss. 2, 1997-05 ,pp. : 125-137

Elsevier

Access to resources Recommend Favorite

Economic Outcomes Associated with Switching Individuals with Schizophrenia Between Risperidone and Olanzapine: Findings from a Large US Claims Database

By Zhao Z.   Namjoshi M.   Barber B.L.   Loosbrock D.L.   Tunis S.L.   Zhu B.   Breier A.  

CNS Drugs, Vol. 18, Iss. 3, 2004-01 ,pp. : 157-164

Adis International

Access to resources Recommend Favorite

Economic Impact of Increased Clinical Intervention Rates in Community Pharmacy: A Randomised Trial of the Effect of Education and a Professional Allowance

By Benrimoj S.I.  

PharmacoEconomics, Vol. 18, Iss. 5, 2000-11 ,pp. : 459-468

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic Assessment of Olanzapine in the Treatment of Refractory Schizophrenia Based on a Pilot Clinical Study

By Sacristán J.A.  

Clinical Drug Investigation, Vol. 15, Iss. 1, 1998-01 ,pp. : 29-35

Adis International

Access to resources Recommend Favorite